Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Cinnamaldehyde Induces Expression of Efflux Pumps and Multidrug Resistance in Pseudomonas aeruginosa.

Tetard A, Zedet A, Girard C, Plésiat P, Llanes C.

Antimicrob Agents Chemother. 2019 Sep 23;63(10). pii: e01081-19. doi: 10.1128/AAC.01081-19. Print 2019 Oct.

PMID:
31383658
2.

Sexual Dysfunction and Quality of Life in Chronic Heroin-Dependent Individuals on Methadone Maintenance Treatment.

Llanes C, Álvarez AI, Pastor MT, Garzón MÁ, González-García N, Montejo ÁL.

J Clin Med. 2019 Mar 7;8(3). pii: E321. doi: 10.3390/jcm8030321.

3.

Constitutive Activation of MexT by Amino Acid Substitutions Results in MexEF-OprN Overproduction in Clinical Isolates of Pseudomonas aeruginosa.

Juarez P, Broutin I, Bordi C, Plésiat P, Llanes C.

Antimicrob Agents Chemother. 2018 Apr 26;62(5). pii: e02445-17. doi: 10.1128/AAC.02445-17. Print 2018 May.

4.

Role of AxyZ Transcriptional Regulator in Overproduction of AxyXY-OprZ Multidrug Efflux System in Achromobacter Species Mutants Selected by Tobramycin.

Bador J, Neuwirth C, Grangier N, Muniz M, Germé L, Bonnet J, Pillay VG, Llanes C, de Curraize C, Amoureux L.

Antimicrob Agents Chemother. 2017 Jul 25;61(8). pii: e00290-17. doi: 10.1128/AAC.00290-17. Print 2017 Aug.

5.

Toxic Electrophiles Induce Expression of the Multidrug Efflux Pump MexEF-OprN in Pseudomonas aeruginosa through a Novel Transcriptional Regulator, CmrA.

Juarez P, Jeannot K, Plésiat P, Llanes C.

Antimicrob Agents Chemother. 2017 Jul 25;61(8). pii: e00585-17. doi: 10.1128/AAC.00585-17. Print 2017 Aug.

6.

Amino Acid Substitutions Account for Most MexS Alterations in Clinical nfxC Mutants of Pseudomonas aeruginosa.

Richardot C, Juarez P, Jeannot K, Patry I, Plésiat P, Llanes C.

Antimicrob Agents Chemother. 2016 Mar 25;60(4):2302-10. doi: 10.1128/AAC.02622-15. Print 2016 Apr.

7.

Carbapenem resistance in cystic fibrosis strains of Pseudomonas aeruginosa as a result of amino acid substitutions in porin OprD.

Richardot C, Plésiat P, Fournier D, Monlezun L, Broutin I, Llanes C.

Int J Antimicrob Agents. 2015 May;45(5):529-32. doi: 10.1016/j.ijantimicag.2014.12.029. Epub 2015 Feb 12.

PMID:
25735764
8.

Label-free SRM-based relative quantification of antibiotic resistance mechanisms in Pseudomonas aeruginosa clinical isolates.

Charretier Y, Köhler T, Cecchini T, Bardet C, Cherkaoui A, Llanes C, Bogaerts P, Chatellier S, Charrier JP, Schrenzel J.

Front Microbiol. 2015 Feb 10;6:81. doi: 10.3389/fmicb.2015.00081. eCollection 2015.

9.

Diversity of β-lactam resistance mechanisms in cystic fibrosis isolates of Pseudomonas aeruginosa: a French multicentre study.

Llanes C, Pourcel C, Richardot C, Plésiat P, Fichant G, Cavallo JD, Mérens A; GERPA Study Group.

J Antimicrob Chemother. 2013 Aug;68(8):1763-71. doi: 10.1093/jac/dkt115. Epub 2013 Apr 29.

PMID:
23629014
10.

Complexity of resistance mechanisms to imipenem in intensive care unit strains of Pseudomonas aeruginosa.

Fournier D, Richardot C, Müller E, Robert-Nicoud M, Llanes C, Plésiat P, Jeannot K.

J Antimicrob Chemother. 2013 Aug;68(8):1772-80. doi: 10.1093/jac/dkt098. Epub 2013 Apr 14.

PMID:
23587654
11.

Evidence for induction of integron-based antibiotic resistance by the SOS response in a clinical setting.

Hocquet D, Llanes C, Thouverez M, Kulasekara HD, Bertrand X, Plésiat P, Mazel D, Miller SI.

PLoS Pathog. 2012;8(6):e1002778. doi: 10.1371/journal.ppat.1002778. Epub 2012 Jun 14.

12.

Role of the MexEF-OprN efflux system in low-level resistance of Pseudomonas aeruginosa to ciprofloxacin.

Llanes C, Köhler T, Patry I, Dehecq B, van Delden C, Plésiat P.

Antimicrob Agents Chemother. 2011 Dec;55(12):5676-84. doi: 10.1128/AAC.00101-11. Epub 2011 Sep 12.

13.

First description of an RND-type multidrug efflux pump in Achromobacter xylosoxidans, AxyABM.

Bador J, Amoureux L, Duez JM, Drabowicz A, Siebor E, Llanes C, Neuwirth C.

Antimicrob Agents Chemother. 2011 Oct;55(10):4912-4. doi: 10.1128/AAC.00341-11. Epub 2011 Aug 1.

14.

Efflux unbalance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.

Vettoretti L, Plésiat P, Muller C, El Garch F, Phan G, Attrée I, Ducruix A, Llanes C.

Antimicrob Agents Chemother. 2009 May;53(5):1987-97. doi: 10.1128/AAC.01024-08. Epub 2009 Mar 2.

15.

[Isolation and identification of species from the genera Aeromonas, Vibrio, and Plesiomonas from extraintestinal samples in Cuba].

Cabrera R LE, Castro E G, Ramírez A MM, Llop H A, Llanes C R, Castañeda E N, Fernández A A, Bravo F L.

Rev Chilena Infectol. 2007 Jun;24(3):204-8. Epub 2007 May 30. Spanish.

16.

Presumed pseudobacteremia outbreak resulting from contamination of proportional disinfectant dispenser.

Siebor E, Llanes C, Lafon I, Ogier-Desserrey A, Duez JM, Pechinot A, Caillot D, Grandjean M, Sixt N, Neuwirth C.

Eur J Clin Microbiol Infect Dis. 2007 Mar;26(3):195-8.

PMID:
17393202
17.

Genetic analysis of a multiresistant strain of Pseudomonas aeruginosa producing PER-1 beta-lactamase.

Llanes C, Neuwirth C, El Garch F, Hocquet D, Plésiat P.

Clin Microbiol Infect. 2006 Mar;12(3):270-8.

18.

[Two efflux systems expressed simultaneously in clinical Pseudomonas aeruginosa].

Hocquet D, Llanes C, Patry I, El Garch F, Plésiat P.

Pathol Biol (Paris). 2004 Oct;52(8):455-61. French.

PMID:
15465264
19.

Clinical strains of Pseudomonas aeruginosa overproducing MexAB-OprM and MexXY efflux pumps simultaneously.

Llanes C, Hocquet D, Vogne C, Benali-Baitich D, Neuwirth C, Plésiat P.

Antimicrob Agents Chemother. 2004 May;48(5):1797-802.

20.

Propagation of TEM- and PSE-type beta-lactamases among amoxicillin-resistant Salmonella spp. isolated in France.

Llanes C, Kirchgesner V, Plesiat P.

Antimicrob Agents Chemother. 1999 Oct;43(10):2430-6.

21.

In vivo emergence of multidrug-resistant mutants of Pseudomonas aeruginosa overexpressing the active efflux system MexA-MexB-OprM.

Ziha-Zarifi I, Llanes C, Köhler T, Pechere JC, Plesiat P.

Antimicrob Agents Chemother. 1999 Feb;43(2):287-91.

22.

The effect of ethanol and/or food restriction on coenzyme Q in liver in rats.

Willis RA, Anthony M, Loop R, Llanes C, Folkers K.

Mol Aspects Med. 1997;18 Suppl:S205-11.

PMID:
9266523
23.

Molecular analysis of the replication elements of the broad-host-range RepA/C replicon.

Llanes C, Gabant P, Couturier M, Bayer L, Plesiat P.

Plasmid. 1996 Jul;36(1):26-35.

PMID:
8938049
24.

Acetylcholinesterase expression in NTera 2 human neuronal cells: a model for developmental expression in the nervous system.

Llanes C, Collman RG, Hrin R, Kolson DL.

J Neurosci Res. 1995 Dec 15;42(6):791-802.

PMID:
8847741
25.

Cloning and characterization of the Inc A/C plasmid RA1 replicon.

Llanes C, Gabant P, Couturier M, Michel-Briand Y.

J Bacteriol. 1994 Jun;176(11):3403-7.

26.

Replicon typing of 71 multiresistant Serratia marcescens strains.

Llanes C, Couturier M, Asfeld L, Grimont F, Michel-Briand Y.

Res Microbiol. 1994 Jan;145(1):17-25.

PMID:
8090980
27.

Natural killer (NK) cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus-infected patients.

Chehimi J, Starr SE, Frank I, Rengaraju M, Jackson SJ, Llanes C, Kobayashi M, Perussia B, Young D, Nickbarg E, et al.

J Exp Med. 1992 Mar 1;175(3):789-96.

28.

Stability of conjugative and non-conjugative R-plasmids from Serratia marcescens to gyrase inhibitors.

Llanes C, Michel-Briand Y, Thouverez M, Bailly C, Grimont F.

Microbiologica. 1990 Apr;13(2):157-9.

PMID:
2161994
29.

Plasmid prevalence in antibiotic resistant Serratia marcescens.

Llanes C, Michel-Briand Y, Bailly C, Grimont F.

J Chemother. 1989 Jul;1(4 Suppl):311-2. No abstract available.

PMID:
16312416
30.

[Antibiotic resistance plasmids from Serratia marcescens and their elimination by DNA-gyrase inhibitors].

Llanes C, Michel-Briand Y, Couturier M, Thouverez M, Bailly C.

C R Seances Soc Biol Fil. 1989;183(3):240-6. French.

PMID:
2557972

Supplemental Content

Loading ...
Support Center